Overview
Integrated Biosciences is a biopharmaceutical company focused on developing small-molecule therapeutics targeting age-related diseases through the integration of synthetic biology, optogenetics, and artificial intelligence. The company leverages proprietary optogenetic tools to enable precise temporal and spatial control of biological pathways, generating high-fidelity datasets that inform AI-driven drug discovery. By combining advanced chemistry with machine learning, Integrated Biosciences aims to systematically explore previously inaccessible chemical space and identify novel therapeutic candidates. The company's ultimate mission extends beyond treating age-related diseases to fundamentally rewriting the biology of aging itself, positioning itself at the intersection of regenerative medicine and computational drug discovery.